Drugs for children and adolescents are in short supply across Europe, warn paediatrician associations in Switzerland, Germany, Austria, France and Italy. They are calling on health ministers to address the significant shortage quickly, reliably and permanently.
This content was published on
1 minute
Keystone-SDA/ts
Italiano
it
I pediatri chiedono di intervenire contro la carenza di medicinali
They made the demand in open letters to their respective health ministers, the Swiss Paediatricians Association said on MondayExternal link. The Swiss letter was addressed to Alain Berset.
“Just a few years ago it was unimaginable that the health of our children and adolescents would be permanently endangered by acute shortages in the availability of, for example, antibiotics, antipyretics and painkillers, asthma medicines and vaccines,” they wrote.
Children and adolescents need comparatively few and relatively inexpensive medicines, which are not necessarily interchangeable with medicines for adults, they explained. “The shortages would mean that treatments could no longer be carried out in a manner suitable for children and in accordance with the therapy guidelines.”
“The insufficient production and storage of basic medicines for children violates this right,” they said.
More
More
Pharmasuisse wants to reduce dependence on Asia
This content was published on
The Swiss pharmaceutical industry should be less dependent on active ingredients from Asia, says the president of the industry umbrella organisation.
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
WHO braces for staff cuts in Geneva amid US funding withdrawal
This content was published on
WHO’s Director-General warned US budget cuts are putting the agency in financial trouble, leading to management cuts in Geneva.
Parmelin meets Swiss businesses in US as IMF predicts 0.9% growth for Switzerland
This content was published on
Economics Minister Guy Parmelin met Swiss businesses in the US during IMF and World Bank meetings. The IMF now forecasts 0.9% GDP growth for Switzerland.
An atomic ‘tick-tock’ with Swiss technology heads to space to test the Einstein effect
This content was published on
On Monday, the European Space Agency (ESA) launched the ACES set of atomic clocks to measure the effect of gravity on the passage of time.
Swiss Guard swearing-in ceremony postponed following Pope Francis death
This content was published on
The swearing-in ceremony of the Pontifical Swiss Guard, which usually takes place on May 6 each year, has been postponed to a date to be announced next autumn.
Swiss medical device maker Ypsomed to sell diabetes business
This content was published on
Bern-based injection device manufacturer Ypsomed announced on Tuesday that it was selling its diabetes-related activities.
Award-winning Swiss author and scholar Peter von Matt dies aged 87
This content was published on
The Alemannic writer and former professor of German literature Peter von Matt died on Monday in Zurich at the age of 87, following a long illness.
Swiss foreign minister spoke with Iranian counterpart about US dialogue
This content was published on
Swiss Foreign Minister Ignazio Cassis has spoken with his Iranian counterpart Abbas Araghchi about the current dialogue between the US and Iran.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Faced with shortages, Switzerland plans to boost drug stocks
This content was published on
Faced with the current shortage of medicines, Bern wants to extend mandatory reserves of drugs and the obligation to declare stocks.
This content was published on
Switzerland is experiencing medicine shortages due to supply chain issues linked to Covid lockdowns in China and the Ukraine war.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.